Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases

NCT06311851 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Metastatic Cancer
Liver Metastases

Interventions

DRUG: Bevacizumab

Sponsor

Pardis Noor Medical Imaging and Cancer Center